The Lancet4h
Non-invasive tests for assessing liver fibrosis and cirrhosis in chronic hepatitis B
Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...
Rolling Out6h
Silent signs your liver is crying for help
Dr. Sarah Chen, chief hepatologist at Metropolitan Liver Center, explains that the liver communicates distress through subtle ...
Treating liver fibrosis and metabolic dysfunction-associated steatohepatitis: Research identifies novel mechanism
Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...
Researchers identify Lhx2 as key gene in hepatic stellate cells regulating liver regeneration and fibrosis
A research team has identified the transcription factor Lhx2 (LIM homeobox protein 2) as a key regulator in hepatic stellate ...
Disappearance of Decompensated Liver Cirrhosis Episodes After Treatment with Can-Fite's Namodenoson
Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030Ramat Gan, Israel, Feb. 18, 2025 (GLOBE ...
Can-Fite reports disappearance of decompensated liver cirrhosis episodes
Can-Fite BioPharma (CANF) announced a significant clinical development: the disappearance of episodes of decompensated liver cirrhosis ...